Abstract

Purpose: To construct a dose monitoring system based on an endorectal balloon coupled to thin scintillating fibers to study the dose to the rectum in proton therapy of prostate cancer. Method: A Geant4 Monte Carlo toolkit was used to simulate the proton therapy of prostate cancer, with an endorectal balloon and a set of scintillating fibers for immobilization and dosimetry measurements, respectively. Results: A linear response of the fibers to the dose delivered was observed to within less than 2%. Results obtained show that fibers close to the prostate recorded higher dose, with the closest fiber recording about one-third of the dose to the target. A 1/r 2 (r is defined as center-to-center distance between the prostate and the fibers) decrease was observed as one goes toward the frontal and distal regions. A very low dose was recorded by the fibers beneath the balloon which is a clear indication that the overall volume of the rectal wall that is exposed to a higher dose is relatively minimized. Further analysis showed a relatively linear relationship between the dose to the target and the dose to the top fibers (total 17), with a slope of (-0.07 ± 0.07) at large number of events per degree of rotation of the modulator wheel (i.e., dose). Conclusion: Thin (1 mm × 1 mm), long (1 m) scintillating fibers were found to be ideal for real time in-vivo dose measurement to the rectum during proton therapy of prostate cancer. The linear response of the fibers to the dose delivered makes them good candidates as dosimeters. With thorough calibration and the ability to define a good correlation between the dose to the target and the dose to the fibers, such dosimeters can be used for real time dose verification to the target. ----------------------------------- Cite this article as : Tesfamicael BY, Avery S, Gueye P, Lyons D, Mahesh M. Scintillating fiber based in-vivo dose monitoring system to the rectum in proton therapy of prostate cancer: A Geant4 Monte Carlo simulation. Int J Cancer Ther Oncol 2014; 2 (2):02024. DOI: http://dx.doi.org/10.14319/ijcto.0202.4

Highlights

  • Prostate cancer is the second leading cause of cancer related death in men, with estimated deaths of about 29,720 for 2013.1-4 A number of treatment options are available for prostate cancer patients

  • The spread out Bragg peak (SOBP) generated for a 200 MeV proton beam is compared to the measured data from Hampton University Proton Therapy Institute (HUPTI) in Figure 1

  • The use of an endorectal balloon coupled to thin scintillating fibers was studied as a potential dose monitoring system in proton therapy of prostate cancer

Read more

Summary

Introduction

Prostate cancer is the second leading cause of cancer related death in men, with estimated deaths of about 29,720 for 2013.1-4 A number of treatment options are available for prostate cancer patients.

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call